06234
Aluminum phosphate monobasic solution
~50% in H2O
Synonym(s):
Aluminum dihydrogen phosphate, prim-Aluminum phosphate
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
concentration
~50% in H2O
Quality Level
density
1.5 g/mL at 20 °C
SMILES string
[Al+3].OP(O)([O-])=O.OP(O)([O-])=O.OP(O)([O-])=O
InChI
1S/Al.3H3O4P/c;3*1-5(2,3)4/h;3*(H3,1,2,3,4)/q+3;;;/p-3
InChI key
RGPUVZXXZFNFBF-UHFFFAOYSA-K
Related Categories
Application
Aluminum phosphate monobasic solution can be used to prepare a Ni-based catalyst named Ni-SAPO-34, which is used in the conversion of methanol to olefins.
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Dam. 1
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Synthesis and characterization of a catalytically active nickel silicoaluminophosphate catalyst for the conversion of methanol to ethene
Chemistry of Materials, 3(4), 667-672 (1991)
Archives of pharmacal research, 35(9), 1621-1628 (2012-10-12)
Two types of radioiodinated plasma driven antigens, heat-inactivated (¹²⁵I-h-HBsAg) and formalin-inactivated HBsAg (¹²⁵I-f-HBsAg) were investigated for the effect of immunoadjuvant, aluminium phosphate (AP) on pharmacokinetics, organ distribution and humoral immunity of differently inactivated hepatitis B surface antigens (HBsAg) in rats.
Expert review of vaccines, 11(12), 1405-1413 (2012-12-21)
A subunit vaccine, RBD-S, is under development to prevent severe acute respiratory syndrome (SARS) caused by SARS coronavirus (SARS-CoV), which is classified by the US NIH as a category C pathogen. This vaccine is comprised of a recombinant receptor-binding domain
Vaccine, 30(19), 2981-2988 (2012-03-03)
We investigated the immunogenicity, stability and adsorption properties of an experimental pneumococcal vaccine composed of three protein vaccine antigens; Pneumococcal histidine triad protein D, (PhtD), Pneumococcal choline-binding protein A (PcpA) and genetically detoxified pneumolysin D1 (PlyD1) formulated with aluminum salt
Archives of virology, 158(7), 1523-1531 (2013-03-05)
We have previously demonstrated that vaccination with a subunit dengue vaccine containing a consensus envelope domain III with aluminum phosphate elicits neutralizing antibodies against all four serotypes of dengue virus in mice. In this study, we evaluated the immunogenicity of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service